Advertisement
Home Tags Liver Disease: Misc.

Tag: Liver Disease: Misc.

Type 2 diabetes mellitus is a risk factor for progression of liver fibrosis in patients with nonalcoholic fatty liver disease

T2DM Is Risk Factor for Liver Fibrosis Progression in NAFLD

0
In multivariate analysis, age, albumin concentration, T2DM independently tied to progression

Digestive Disease Week, May 18-21

0
Digestive Disease Week 2019 The annual Digestive Disease Week, sponsored by the American Association for the Study of Liver Diseases, American Gastroenterological Association,...
The risks for cirrhosis and hepatocellular carcinoma are increased for patients with a recorded diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Adverse Liver Outcomes Up With Diagnosis of NAFLD/NASH

0
Baseline diagnosis of diabetes independent predictor of advanced liver disease diagnosis
The prevalence of alcoholic fatty liver disease has remained stable among U.S. adults

U.S. Prevalence of Alcoholic Fatty Liver Disease Stable at 4.7 Percent

0
But prevalence of AFLD with stage 2 or greater fibrosis, AFLD with stage 3 or greater fibrosis increased
A considerable proportion of young adults have fibrosis and steatosis of the liver

Fibrosis, Steatosis of the Liver Observed in Some Young Adults

0
Within Avon Longitudinal Study cohort, 2.4 percent of young adults had fibrosis; 20.8 percent had steatosis
Nonalcoholic fatty liver disease is becoming an increasingly important cause of liver disease and liver mortality among patients with HIV

Nonalcoholic Fatty Liver Disease Burden Up Among HIV-Infected

0
NAFLD becoming increasingly important cause of liver disease, liver mortality
The risk of stillbirth is increased in women with intrahepatic cholestasis of pregnancy when serum bile acids concentrations are ≥100 µmol/L or more

Stillbirth Risk Up With High Serum Bile Acids in Pregnancy

0
Higher risk of stillbirth with serum bile acids ≥100 µmol/L in intrahepatic cholestasis of pregnancy
From 2003 to 2016

Improved Outcomes Seen With Liver Grafts From Older Donors

0
However, liver graft discard from older donors remained increased from 2003 to 2016
For adults with chronic hepatitis C virus infection

Direct-Acting Antivirals Cut Mortality in Chronic Hepatitis C

0
Mortality, hepatocellular carcinoma risk reduced after adjustment for potential confounders
The current method for ranking patients on the liver transplantation wait list may not prioritize some of the sickest candidates

Liver Transplant Wait List May Not Prioritize High-Risk Patients

0
Patients with ACLF-3 with a MELD-Na score less than 25 may benefit from prioritization